Oncotelic Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Oncotelic Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $130.77K.
- Oncotelic Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $60.19K, a 45.12% decline year-over-year.
- Oncotelic Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2022-06-30 was $46.82K, a 52.73% decline year-over-year.
- Oncotelic Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2022-03-31 was $51.80K.
- Oncotelic Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2025 was $1.50M.
- Oncotelic Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2022 was $158.82K, a 62.21% decline from fiscal 2021.
- Oncotelic Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2021 was $420.30K.
- Oncotelic Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2019 was $83.00K, a 65.42% decline from fiscal 2018.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $130.77K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $1.50M 10-K · filed 2026-04-15 | |
| 2022-12-31 | $158.82K 10-K · filed 2024-04-12 | |
| 2022-09-30 | $60.19K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $46.82K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $51.80K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $420.30K 10-K/A · filed 2023-04-20 | |
| 2021-09-30 | $109.69K 10-Q · filed 2022-11-18 | |
| 2021-06-30 | $99.06K 10-Q · filed 2022-11-18 | |
| 2019-12-31 | $83.00K 10-K · filed 2021-04-15 | |
| 2019-03-31 | $83.00K 10-Q · filed 2020-11-16 | |
| 2018-12-31 | $240.00K 10-K · filed 2020-05-14 | |
| 2018-03-31 | $200.00K 10-Q · filed 2019-11-19 | |
| 2013-12-31 | $9.10M 10-K · filed 2015-03-30 | |
| 2012-12-31 | $2.05M 10-K · filed 2015-03-30 |